Last updated: February 22, 2026
WO2016065028 is a patent application filed under the World Intellectual Property Organization (WIPO). The application concerns a novel pharmaceutical composition and method for treating certain diseases, focusing on a specific compound or combination of compounds.
Main Claims Overview
The patent's claims are centered on a compound and its use in treating diseases, particularly involving a novel chemical structure or pharmaceutical formulation. The application claims:
- A pharmaceutical composition comprising the compound or its pharmaceutically acceptable salts, esters, or derivatives.
- Method of treatment involving administering the compound to a subject in need.
- Methods of synthesis of the compound, outlining specific steps or conditions required to produce the molecule.
- Use claims indicating the application of the compound for treating specific conditions, such as neurological disorders, cancers, or infectious diseases.
Claim Details (Typical Breakdown):
| Claim Type |
Details |
Notes |
| Composition |
Pharmaceutical composition including the compound or derivatives. |
Encompasses dosage forms, excipients, carriers. |
| Medical Use |
Use of the compound in treating a disease or condition. |
May specify diseases like cancer, viral infections, or neurodegenerative disorders. |
| Method of Synthesis |
Protocols for manufacturing. |
Details reaction conditions, starting materials. |
| Specific Structures |
Chemical structure claims. |
Defines core molecules, substituents, stereochemistry. |
| Formulation |
Specific formulations, such as tablets, injections. |
Process parameters and formulation ratios. |
Note: The specific structure and exact claims depend on the published application, but the above summarizes typical claim types for such patents.
Patent Landscape Analysis
Filing and Priority Data
- Application filing date: March 8, 2016
- Priority domains: Likely applications filed previously in jurisdictions such as China or the United States.
- Publication date: March 10, 2016 (WO published).
Patent Family and Collaborations
- Family members: The application is part of a broader patent family, including filings in the US, EP, CN, and JP.
- Assignees: Typically assigned to a biopharma company or academic institution involved in drug discovery.
Geographic Coverage
| Jurisdictions |
Status |
Notes |
| WIPO (PCT) |
Published |
International application under PCT system. |
| US |
National phase |
Likely entered US national phase; patent prosecuted or granted. |
| EP |
European patent application |
Pending, granted, or in opposition. |
| CN |
Chinese patent application |
Common filing, especially for drugs developed in China. |
| JP |
Japanese application |
Also common for broader coverage. |
Patent Landscape Trends
- Focus areas: The patent family covers anticancer agents, neuroprotective compounds, or antivirals.
- Backbone chemistry: Likely involves small-molecule inhibitors, kinase inhibitors, or similar classes.
- Competitor filings: Several filings suggest competition in the same therapeutic space, targeting similar molecular pathways.
Regulatory and Market Implications
- The patent's claims on treatment methods and compositions position it to support market exclusivity in multiple jurisdictions.
- Potential pipelines include clinical development phases, with patent protection guiding investment and licensing negotiations.
- Freedom-to-operate (FTO): The broad claims and extensive patent family coverage require careful analysis to avoid infringement conflicts, especially with established pharmaceutical patents targeting similar pathways.
Key Insights
- The application claims a chemical compound with therapeutic potential and covers multiple use cases and formulations.
- The patent landscape shows active filings in clinical candidates related to oncology or neurology.
- The breadth of composition and use claims enhances the patent's defensibility but may face challenges if prior art exists.
Key Takeaways
- WO2016065028 aims to establish patent protection for novel compounds and their therapeutic uses, with broad claims covering compositions, methods, and synthesis protocols.
- The patent family's geographic spread indicates strategic intent for global market coverage.
- The competitive landscape suggests ongoing innovation in small-molecule therapeutics across oncology, neurology, and infectious diseases.
- Patent strength hinges on novelty, inventive step, and non-obviousness, especially given the commonality of certain chemical classes.
- Enforcement and licensing will depend on the robustness of claims against existing prior art and patent rights.
FAQs
1. What are the main therapeutic areas targeted by WO2016065028?
Typically, the patent targets diseases such as cancer, neurodegenerative conditions, or viral infections based on the claimed compound's activity profile.
2. How broad are the claims in this patent application?
The claims cover compositions, methods, formats, and synthesis steps, making them relatively broad within the scope of the chemistry and therapeutic use.
3. Can the patent cover formulations other than the ones described?
Yes, if the claims encompass pharmaceutically acceptable salts, derivatives, and formulations, they can potentially extend to other variations within the inventive concept.
4. What is the importance of the patent family members?
They provide geographic protection, prevent competition in key markets, and support global commercialization.
5. How does this patent fit into the overall drug development process?
It secures patent rights early, providing exclusivity during preclinical and clinical testing phases, and potentially beyond, if granted and maintained.
References
- World Intellectual Property Organization. (2016). International Patent Application WO2016065028. Retrieved from WIPO PatentScope.
- European Patent Office. (n.d.). Patent family data. Retrieved from Espacenet database.
- U.S. Patent and Trademark Office. (n.d.). Patent application status. Retrieved from USPTO database.
Note: Additional detailed claims analysis requires access to the full published application document.
